Interrupted or continuous slowly absorbable Sutures - Evaluation of abdominal Closure Techniques

BBD Aesculap GmbH (Germany)0 个研究点目标入组 600 人开始时间: 2004年3月8日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Aged equal or greater than 18 years
•2. Expected survival time more than 12 months
•3. Patients undergoing primary and elective median laparotomy (patients with prior laparoscopy or abdominal operation via paramedian incision (e.g. appendectomy) may be included in the trial)
•4. Body mass index (BMI) less than 35
•5. Expected length of incision greater than 15 cm
•6. Patient must be able to give informed consent
•7. Patient has given informed consent

•1. Peritonitis
•2. Emergency surgery
•3. Participation in another intervention-trial with interference of intervention and outcome of this study
•4. Coagulopathy: a group of disorders of the blood clotting (coagulation) system in which bleeding is prolonged and excessive with abnormal values in the blood laboratory
•5. Severe psychiatric or neurologic diseases
•6. Lack of compliance
•7. Drug- and/or alcohol-abuse according to local standards
•8. Current immunosuppressive therapy (more than 40 mg of a corticoid per day or azathioprin)
•9. Chemotherapy within 2 weeks before operation
•10. Radiotherapy of the abdomen completed longer than 8 weeks before operation
•11. Inability to follow the instructions given by the investigator or the telephone interviewer (insufficient command of language, dementia, lack of time)
•12. Lack of informed consent

发起方

BBD Aesculap GmbH (Germany)